Novartis Boosts Immunology Investment with IFM Tre Acquisition

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 4 (Table of Contents)

Published: 6 Apr-2019

DOI: 10.3833/pdr.v2019.i4.2416     ISSN: 1756-7874

Section: Mergers & Acquisitions



Novartis has agreed to acquire anti-inflammatory drug specialist, IFM Tre, a subsidiary company of IFM Therapeutics, for up to US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details